Progressing gastrointestinal health through better data

Approximately 60 to 70 million people are affected by a digestive disease, according to the U.S. Department of Health and Human Services, putting an estimated $135 billion burden on our healthcare system. As gut health declines, the need for innovative therapies rises. ObvioHealth’s virtual study design and user-friendly app breaks down barriers to traditional GI research. Stool samples can be collected at home and sent to a lab. Patient reported data on taboo topics like flatulence and bowel movements is collected through the app without the need for face-to-face conversations with a physician. This provides higher compliance and more complete data. See below for more on ObvioHealth’s experience in GI clinical research.

Recruitment

Because our studies are virtual, we are not geographically tied to a site location. This allows us to recruit for our studies anywhere in the world. This often makes recruitment faster and less expensive. Symptoms of GI disorders can be physically uncomfortable, but also quite embarrassing to discuss with a doctor. Disorders that affect the bowel can create embarrassing face to face interactions which might prevent participation in traditional on-site research. Virtual trial models like our own alleviate the need to visit a doctor’s office to report symptoms or outcomes in-person.

Data Capture

It’s not one size fits all. Different studies require different technologies to ensure you’re capturing the most accurate data from enrolled patients. From image and audio capture to artificial intelligence, let us help you design a study that meets your endpoints while keeping patients engaged.

Contact Us

Compliance & Retention

Our easy-to-use, convenient app increases our compliance & retention rates. We send push notifications to help remind participants to complete study activities. Our study team is always available to answer questions.

Remote Monitoring

Our study team can monitor real-world data in real time. This allows for immediate AE detection and course correction.

Measuring the impact of rice vinegar on blood pressure in prehypertensive adults

• 93 % product compliance
• 56,286 data points evaluated in real time

ObvioHealth deployed a targeted digital recruitment strategy to enroll 128 patients with a blood pressure of 120-139/80-89 mmHg, living in the Houston and Atlanta areas. The study successfully achieved a diverse study population: 41% Caucasian, 39% African American, 20% "other race.”

Read Full Case Study

Currently Recruiting

Assessing the efficacy of a medical device on pelvic floor dysfunction

Nearly a quarter of women in the United States have a pelvic floor disorder, according to the NIH. We’re in the midst of a clinical trial to evaluate a new treatment for these all-too-common pelvic-floor conditions.

Read Full Case Study

Gastrointestinal Virtual Clinical Trials

Progressing gastrointestinal health through better data

Proving the efficacy of a new treatment for menopausal symptoms

ObvioGo

Curious How You Could Take Your Dermatology Trial Virtual?

Delivering Better Data for Your GI Study

Recruitment

Data Capture

Contact Us

Compliance & Retention

Remote Monitoring

Read More

Measuring the impact of rice vinegar on blood pressure in prehypertensive adults

Currently Recruiting